BOSTON--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell has been selected for the fifth annual Innovators Challenge that takes place during the Partners Healthcare’s Connected Health Symposium on October 29. The Innovators Challenge was established to showcase products that are genuinely new and potentially game changing for connected health.
“We are proud that Quell was selected as one of 10 finalists by a panel of judges from the Connected Health Symposium,” said Shai Gozani, M.D., Ph.D., President and CEO of NeuroMetrix, Inc. “Quell is a great example of the impact of innovation in wearable technology and connected health.”
Quell is an easy-to-use, over-the-counter device for relief of chronic pain. This wearable device utilizes NeuroMetrix's wearable intensive nerve stimulation (WINS) technology to provide pain relief. In a recent clinical study, Quell improved chronic pain and overall health in 81% of participants. Quell is currently available through select healthcare professionals, retailers, and online at www.QuellRelief.com.
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
About the Connected Health Symposium
The Connected Health Symposium is a change-agent conference that promotes innovative thinking and the application of personal consumer health technologies to support new models of care delivery. With a focus on trends at the intersection of technology and new models of health care delivery, the Symposium convenes thought leaders in an effort to grow the rapidly-expanding connected health marketplace.